Concepedia

V S Goldmacher

VS

Statistics

Publications

15

Citations

1.1K

H-Index

14

Active since

1985

Affiliations

Dana-Farber Cancer Institute(Current)

ImmunoGen (United States)

V S Goldmacher is an author at Dana-Farber Cancer Institute specializing in immunology, medicine, and cell biology.

Top concepts

Publications per year

1985–1997

15

Publications

15

Humanization of murine monoclonal antibodies through variable domain resurfacing.

Michael Roguska, Jim Thuesen Pedersen, C Keddy et al. · Proceedings of the National Academy of Sciences · 1994 · 201 citations · Full text

Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion

ML Grossbard, AS Freedman, Jerome Ritz et al. · Blood · 1992 · 171 citations · Full text

Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.

Michael L. Grossbard, JM Lambert, V S Goldmacher et al. · Journal of Clinical Oncology · 1993 · 161 citations

An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use.

JM Lambert, V S Goldmacher, Albert R. Collinson et al. · PubMed · 1991 · 118 citations

, , +21

The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13.

L E Bradbury, V S Goldmacher, Thomas F. Tedder · The Journal of Immunology · 1993 · 107 citations · Full text

, , +16

1–5 of 15